TREATMENT OF OPHTHALMOLOGIC DISEASES

The current invention relates to the use of antibodies which bind to VEGF and ANG2 for the treatment of ophthalmologic diseases. La présente invention concerne l'utilisation d'anticorps qui se fixent sur VEGF et ANG2 pour le traitement de maladies ophtalmologiques.

Saved in:
Bibliographic Details
Main Authors SAHNI, Jayashree, OSBORNE, Aaron, WEIKERT, Robert James
Format Patent
LanguageEnglish
French
Published 15.08.2019
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The current invention relates to the use of antibodies which bind to VEGF and ANG2 for the treatment of ophthalmologic diseases. La présente invention concerne l'utilisation d'anticorps qui se fixent sur VEGF et ANG2 pour le traitement de maladies ophtalmologiques.
Bibliography:Application Number: WO2019EP52704